Induction and waning of specific immune mechanisms against Bordetella Pertussis after infection.

Completed

• Conditions: pertussis; whooping cough; 10004018

• Registration Number: NL-OMON36878
• Lead Sponsor: RIVM

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 480

Inclusion Criteria

I: Patients being within a 4 weeks period after a laboratory-confirmed diagnosis of pertussis
II: Household contact of I
III: Subjects being recovered or recovering from a laboratory-confirmed pertussis infection which was diagnosed > 4 weeks earlier

Exclusion Criteria

A: Immunosuppressive medical treatment, like cytostatics and prednisolons that might interfere with the results of the study, within the previous 3 months.
B: Any known primary or secondary immunodeficiency
C: Bleeding disorder

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified